STAAR Surgical Company (SR3.F)

37.22 -1.00 (-2.62%) At close: 08:05AM CEST

STAAR Surgical Company

25651 Atlantic Ocean Drive
Lake Forest, CA 92630
United States
626 303 7902
https://www.staar.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 1,056

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Corporate governance

STAAR Surgical Company’s ISS governance QualityScore as of 1 June 2024 is 5. The pillar scores are Audit: 3; Board: 5; Shareholder rights: 7; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.